CRA Roundtable: Opportunities and Challenges in Rare Diseases
As part of CRA’s issues leadership initiative to challenge industry thinking on rare diseases, we assembled a panel of CRA experts to discuss the opportunities...
Ned Kitfield has extensive experience providing commercial decision support for large and small biotech, pharmaceutical, and healthcare companies.
While Ned has worked across a broad spectrum of therapeutic categories, he brings particular insight into rare and ultra-orphan diseases. He expertise includes everything from commercialization strategy to advanced analytics and primary market research designed for these often overlooked rare spaces.
Prior to joining CRA in 2017, Ned acted as one of three Managing Directors at C1 Consulting, a life sciences decision support firm, where he headed up the Rare Disease Practice for 3 years. Ned also held a variety of senior level sales and commercial roles at Shire, Sanofi, Bayer and Adolor where he was responsible for domestic and global commercial operation for a variety of specialty and orphan products.